(Q41533462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chang Mei-hwei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Etienne Sokal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kyung Mo Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Maureen M Jonas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kathleen B Schwarz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Deirdre Kelly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Philip Rosenthal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Dumitru Oraseanu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Laurie Reynolds

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Alexandra Thiry

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Peter Ackerman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

16 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

377-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26223345%20AND%20SRC:MED&resulttype=core&format=json

Chronic hepatitis B in children and adolescents

20 February 2020

cites work

1 reference

Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

21 January 2018

1 reference

Impact of chronic hepatitis B and interferon-alpha therapy on growth of children

21 January 2018

1 reference

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

21 January 2018

1 reference

Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.

21 January 2018

1 reference

Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

21 January 2018

1 reference

Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

21 January 2018

1 reference

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

21 January 2018

1 reference

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

21 January 2018

1 reference

SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease

21 January 2018

1 reference

Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

21 January 2018

1 reference

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

21 January 2018

1 reference

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

21 January 2018

1 reference

Relationship between viral load and genotypes of hepatitis B virus in children with chronic hepatitis B.

21 January 2018

1 reference

Clinical trial of lamivudine in children with chronic hepatitis B.

21 January 2018

1 reference

Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

21 January 2018

1 reference

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

Long-term treatment with tenofovir in Asian-American chronic hepatitis B patients is associated with abnormal renal phosphate handling

21 January 2018

1 reference

7 January 2021

Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection

1 reference

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

7 January 2021

Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

1 reference

7 January 2021

Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study

1 reference

7 January 2021